Repotrectinib (Tpx-0005) is a next-generation ros1/trk/alk inhibitor that potently inhibits ros1/trk/alk solvent-front mutations

Alexander Drilon, Sai Hong Ignatius Ou, Byoung Chul Cho, Dong Wan Kim, Jeeyun Lee, Jessica J. Lin, Viola W. Zhu, Myung Ju Ahn, D. Ross Camidge, Judy Nguyen, Dayong Zhai, Wei Deng, Zhongdong Huang, Evan Rogers, Juliet Liu, Jeff Whitten, John K. Lim, Shanna Stopatschinskaja, David M. Hyman, Robert C. DoebeleJ. Jean Cui, Alice T. Shaw

Research output: Contribution to journalComment/debatepeer-review

212 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Repotrectinib (Tpx-0005) is a next-generation ros1/trk/alk inhibitor that potently inhibits ros1/trk/alk solvent-front mutations'. Together they form a unique fingerprint.

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences